Tokyo - Delayed Quote JPY

MediPal Holdings Corporation (7459.T)

2,264.50
+12.50
+(0.56%)
At close: May 23 at 3:30:00 PM GMT+9

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in JPY.
NameTitlePayExercisedYear Born
Mr. Shuichi Watanabe Chief Compliance Officer, CEO, President & Representative Director -- -- 1952
Mr. Yuji Sakon MD, GM of Administration Division & Director -- -- 1953
Mr. Toshihide Yoda Senior MD of Investor Relations, GM of Business Development Department & Director -- -- 1963
Mr. Yasuhiro Choufuku Executive VP & Director -- -- 1954
Mr. Shinjiro Watanabe GM of Information Systems Management Division & Director -- -- 1972

MediPal Holdings Corporation

3-1-1 Kyobashi
Chuo-ku
Tokyo, 104-8461
Japan
81 3 3517 5800 https://www.medipal.co.jp
Sector: 
Healthcare

Description

Medipal Holdings Corporation engages in the prescription pharmaceutical wholesale business in Japan. It procures healthcare products related to diagnostics, testing, treatment, and administration comprises medical equipment and medical materials, and clinical diagnostic reagents for use from the pre-symptomatic stage; handles PMS services on contract for manufacturers; and invests in orphan drugs and other products. The company is involved in the wholesale of cosmetics, daily necessities, and OTC pharmaceuticals; animal health products for companion animals; food processing raw materials for agriculture, fisheries, and livestock; and livestock feed additives, seasonings, veterinary medical equipment, packaging materials, industrial chemicals, and other products. In addition, it engages in the contract-based epidemiological studies, clinical studies, etc.; creation of a computerized medical supply database and master product databases for medical facilities; life and non-life insurance agency business; cleaning management; management and operation of distribution centers; commissioned delivery and worker dispatch business; and planning, management, administration, and product and service development for the class A health dispensing pharmacies service brand. Further, the company trades in medical clerks; outsourcing of medical administrative, and medical consulting; and distributes specialty pharmaceuticals. Additionally, it engages in contract logistics services, as well as offers information provision services. Medipal Holdings Corporation serves hospitals, clinics, dispensing pharmacies, drugstores, home centers, convenience stores, supermarkets, discount stores, animal hospitals, livestock and fishery businesses, and processed food manufacturers. The company was formerly known as Mediceo Paltac Holdings Co., Ltd. and changed its name to Medipal Holdings Corporation in October 2009. The company was founded in 1898 and is headquartered in Tokyo, Japan.

Corporate Governance

MediPal Holdings Corporation’s ISS Governance QualityScore as of May 1, 2025 is 10. The pillar scores are Audit: 4; Board: 9; Shareholder Rights: 6; Compensation: 9.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

July 30, 2025 at 6:00 AM UTC - August 4, 2025 at 6:00 AM UTC

MediPal Holdings Corporation Earnings Date

September 29, 2025 at 12:00 AM UTC

Ex-Dividend Date

Recent Events